XBIOTECH INC. Effective Tax Rate
XBIOTECH INC. (XBIT) reported Effective Tax Rate of -0.70% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-13
- XBIOTECH INC. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was -0.70%.
- XBIOTECH INC. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was -0.30%.
- XBIOTECH INC. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was -1.70%, a 950.00% decline year-over-year.
- XBIOTECH INC. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was -0.80%, a 500.00% decline year-over-year.
- XBIOTECH INC. effective income tax rate reconciliation, percent for fiscal 2025 was -0.52%, a 750.00% decline from fiscal 2024.
- XBIOTECH INC. effective income tax rate reconciliation, percent for fiscal 2024 was 0.08%.
- XBIOTECH INC. effective income tax rate reconciliation, percent for fiscal 2023 was -1.00%, a 150.00% decline from fiscal 2022.
- XBIOTECH INC. effective income tax rate reconciliation, percent for fiscal 2022 was 2.00%, a 93.67% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed | Effective Income Tax Rate Reconciliation, Percent 18 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -0.70% 10-Q · filed 2026-08-13 | -1.60% 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -0.30% 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -0.52% 10-K · filed 2026-03-13 | |||||||
| 2025-09-30 | -1.70% 10-Q · filed 2025-11-12 | -0.90% 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -0.80% 10-Q · filed 2026-08-13 | -1.60% 10-Q · filed 2025-08-13 | -0.50% 10-Q · filed 2026-08-13 | |||||
| 2025-03-31 | -0.30% 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | 0.08% 10-K · filed 2026-03-13 | 0.10% 10-K · filed 2025-03-18 | ||||||
| 2024-09-30 | 0.20% 10-Q · filed 2025-11-12 | -0.20% 10-Q · filed 2024-11-13 | 0.00% 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | 0.20% 10-Q · filed 2025-08-13 | 0.00% 10-Q · filed 2025-08-13 | ||||||
| 2024-03-31 | -0.30% 10-Q · filed 2025-05-14 | 0.30% 10-Q · filed 2024-05-10 | ||||||
| 2023-12-31 | -1.00% 10-K · filed 2025-03-18 | |||||||
| 2023-09-30 | -4.40% 10-Q · filed 2024-11-13 | -1.80% 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | 0.80% 10-Q · filed 2024-08-12 | 0.30% 10-Q · filed 2024-08-12 | ||||||
| 2023-03-31 | -0.90% 10-Q · filed 2024-05-10 | 0.90% 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | 2.00% 10-K · filed 2024-03-15 | |||||||
| 2022-09-30 | -23.40% 10-Q · filed 2023-11-09 | 23.40% 10-Q · filed 2022-11-09 | 4.10% 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | 18.30% 10-Q · filed 2023-08-11 | 17.70% 10-Q · filed 2023-08-11 | ||||||
| 2022-03-31 | 16.40% 10-Q · filed 2023-05-10 | 16.41% 10-Q · filed 2022-05-10 | ||||||
| 2021-12-31 | 31.60% 10-K · filed 2023-03-15 | |||||||
| 2021-09-30 | 35.50% 10-Q · filed 2022-11-09 | 38.50% 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | 47.20% 10-Q · filed 2022-08-10 | 39.60% 10-Q · filed 2022-08-10 | 39.65% 10-Q · filed 2021-08-09 | |||||
| 2020-12-31 | 12.50% 10-K · filed 2022-03-15 | |||||||
| 2020-09-30 | 20.90% 10-Q · filed 2021-11-09 | -20.90% 10-Q · filed 2020-11-09 | 12.60% 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | 4.60% 10-Q · filed 2020-08-10 | 9.10% 10-Q · filed 2020-08-10 | ||||||
| 2020-03-31 | 12.50% 10-Q · filed 2020-05-11 | |||||||
| 2019-12-31 | 6.90% 10-K · filed 2022-03-15 | |||||||
| 2019-09-30 | 0.00% 10-Q · filed 2020-11-09 | 0.00% 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | 0.00% 10-Q · filed 2020-08-10 | |||||||
| 2018-12-31 | 0.00% 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |